He is concerned that people who view exercise only as a weight-loss strategy might be less inclined to be physically active after taking one of the new GLP-1 drugs by thinking, Why exercise since I can lose weight with a drug? That would be a big mistake.
It is widely recognised that metformin improves glycaemic control with a good safety profile, weight neutrality or weight loss, lack of associated hypoglycaemia, reduced cardiovascular mortality and low cost [3]
Clinical trials have shown promising results, demonstrating its effectiveness in improving glycemic control and aiding weight loss in individuals with Type 2 diabetes and obesity
Circulation 150, 17811790
Rare but serious gastrointestinal complications include pancreatitis and cholecystitis, which require immediate discontinuation and urgent medical assessment
Supplementation with Pycnogenol(R) improves signs and symptoms of menopausal transition